Open access
105
Views
10
CrossRef citations to date
0
Altmetric
Original Research
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
David C Ford1 Toronto Digestive Disease Associates, Inc, Vaughan Endoscopy Clinic, Vaughan, ON, Canada
, Naomi V Dahl2 AMAG Pharmaceuticals, Inc, Waltham, MA
, William E Strauss2 AMAG Pharmaceuticals, Inc, Waltham, MACorrespondence[email protected]
, Charles F Barish3 Wake Gastroenterology, Wake Research Associates, Raleigh, NC, USA
, David J Hetzel4 Department of Gastroenterology, Royal Adelaide Hospital, Adelaide, SA, Australia
, Kristine Bernard2 AMAG Pharmaceuticals, Inc, Waltham, MA
, Zhu Li2 AMAG Pharmaceuticals, Inc, Waltham, MA
& Lee F Allen2 AMAG Pharmaceuticals, Inc, Waltham, MA
show all
Pages 151-162
|
Published online: 11 Jul 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.